Literature DB >> 20187797

Comparision between sonodynamic effects with protoporphyrin IX and hematoporphyrin on the cytoskeleton of Ehrlich ascites carcinoma cells.

Pan Wang1, Xiaobing Wang, Quanhong Liu, Xia Zhao, Bing Cao, Ping Zhao.   

Abstract

PURPOSE: Our previous work demonstrated that the enhancement of cytotoxicity by protoporphyrin IX (Pp) was significantly higher than hematoporphyrin (Hp), when they were compared at the same ultrasound-exposure conditions, since the cytoskeleton plays a crucial role in numerous cell functions and the effect of sonodynamic therapy (SDT) on cytoskeleton has not been reported yet. So, it is very important to investigate whether SDT has some influence on the cytoskeleton, and it would also be interesting to compare Pp-/ and Hp-mediated SDT on the cytoskeleton.
METHODS: Ehrlich ascites carcinoma (EAC) cells were exposed to ultrasound for up to 15 seconds (1.34 MHz, 1 w/cm(2)) in the presence of 20 microM of Pp or 20 microM of Hp. Cell viability was determined by the trypan blue exclusion test. Morphologic changes were observed under a scanning electron microscope. Cytoskeleton damages were shown by immunofluorescence staining of microtubules, actin microfilaments, and intermediate filaments of vimentin.
RESULTS: Our experiment showed that the extent of cytoskeleton damage in EAC cells increased as time was prolonged, and also which was more significant in the Pp-SDT group than that in the Hp-SDT group at the same time after exposure.
CONCLUSIONS: Results implied that the ultrastructural changes might account for cell destruction and the cytoskeletal components were involved in the cell-damaging process induced SDT treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20187797     DOI: 10.1089/cbr.2008.0604

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  2 in total

1.  Cancer treatment using an optically inert Rose Bengal derivative combined with pulsed focused ultrasound.

Authors:  Yoo-Shin Kim; Valentina Rubio; Jianjun Qi; Rongmin Xia; Zheng-Zheng Shi; Leif Peterson; Ching-Hsuan Tung; Brian E O'Neill
Journal:  J Control Release       Date:  2011-08-17       Impact factor: 9.776

2.  Multifunctional Theranostic Nanoparticles for Enhanced Tumor Targeted Imaging and Synergistic FUS/Chemotherapy on Murine 4T1 Breast Cancer Cell.

Authors:  Zhengyue Kang; Min Yang; Xiaoling Feng; Hongjian Liao; Zhifei Zhang; Yonghong Du
Journal:  Int J Nanomedicine       Date:  2022-05-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.